A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Constellation Pharmaceuticals
Hoffmann-La Roche
BeiGene
Astex Pharmaceuticals, Inc.
Genelux Corporation
Takeda
Amgen Research (Munich) GmbH
AVEO Pharmaceuticals, Inc.
Centocor, Inc.